tiprankstipranks
Trending News
More News >
Nyxoah (NYXH)
NASDAQ:NYXH
US Market
Advertisement

Nyxoah (NYXH) Earnings Dates, Call Summary & Reports

Compare
132 Followers

Earnings Data

Report Date
Mar 19, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.62
Last Year’s EPS
-0.54
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 13, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
Nyxoah's third quarter 2025 earnings call highlighted strong U.S. launch results, increased surgeon and payer adoption, and significant revenue growth. However, these achievements were offset by increased operating losses, a reduced cash position, and a decline in gross margin. Despite these challenges, the overall sentiment remains optimistic due to strategic financial positioning and market enthusiasm.
Company Guidance
During Nyxoah's third-quarter 2025 earnings call, the company provided detailed guidance and metrics reflecting their successful U.S. launch of the Genio system post-FDA approval. The company reported generating USD 231,000 in revenue from 15 Genio implants performed across nine accounts by the end of October. They focused on training 111 out of 125 targeted surgeons and submitted 102 value analysis committee packages, with 35 approvals received. Reimbursement progress included securing agreements with Medicare and 10 private payers, achieving a 100% success rate on 21 out of 63 prior authorizations submitted. The company aims to expand its U.S. commercial organization, targeting 400 high-volume hypoglossal nerve sites, and expects global revenue between EUR 3.4 million and EUR 3.6 million in Q4 2025.
Positive U.S. Launch of Genio
Following FDA approval, Nyxoah's Genio device received strong enthusiasm in the U.S., generating USD 231,000 in revenue during Q3 and completing 15 implants across 9 accounts by the end of October.
Surgeon and Payer Adoption
111 surgeons were trained, 102 value analysis committee submissions completed, and reimbursement secured with Medicare and 10 private payers including UnitedHealthcare, Blue Cross Blue Shield, and Cigna.
Significant Revenue Growth
Reported revenue of EUR 2 million in Q3 2025, a 56% increase from EUR 1.3 million in Q3 2024.
Strategic Financial Positioning
Nyxoah secured up to $77 million in funding, including a $25 million private equity placement and a $52 million convertible bond, ensuring capital runway into Q1 2027.

Nyxoah (NYXH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

NYXH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 19, 2026
2025 (Q4)
-0.62 / -
-0.537
Nov 13, 2025
2025 (Q3)
-0.68 / -0.73
-0.575-27.02% (-0.16)
Aug 18, 2025
2025 (Q2)
-0.66 / -0.64
-0.496-28.74% (-0.14)
May 14, 2025
2025 (Q1)
-0.55 / -0.69
-0.481-44.10% (-0.21)
Mar 13, 2025
2024 (Q4)
-0.54 / -0.54
-0.439-22.16% (-0.10)
Nov 06, 2024
2024 (Q3)
-0.53 / -0.57
-0.308-86.47% (-0.27)
Aug 06, 2024
2024 (Q2)
-0.49 / -0.50
-0.5184.25% (+0.02)
May 14, 2024
2024 (Q1)
-0.49 / -0.48
-0.5339.78% (+0.05)
Mar 05, 2024
2023 (Q4)
-0.41 / -0.44
-0.59626.26% (+0.16)
Nov 08, 2023
2023 (Q3)
-0.50 / -0.31
-0.28-9.92% (-0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

NYXH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 13, 2025
$5.31$5.00-5.84%
Aug 18, 2025
$6.57$6.27-4.57%
May 14, 2025
$5.78$6.06+4.84%
Mar 13, 2025
$9.73$10.05+3.29%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Nyxoah (NYXH) report earnings?
Nyxoah (NYXH) is schdueled to report earning on Mar 19, 2026, After Close (Confirmed).
    What is Nyxoah (NYXH) earnings time?
    Nyxoah (NYXH) earnings time is at Mar 19, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is NYXH EPS forecast?
          NYXH EPS forecast for the fiscal quarter 2025 (Q4) is -0.62.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis